Kenall Colors Healthcare and High Abuse Spaces with MedMaster Saturn™
KENOSHA, Wis., April 29, 2025 /PRNewswire/ -- Kenall is pleased to introduce the new MedMaster and Millenium Saturn™ series, where robust durability meets a sleek modern design aesthetic for behavioral health and high abuse settings. This innovative family offers optional synchronous or dual light engines, allowing control of the inner and outer light rings, independently or together. Featuring narrow spectrum static color, with a variety of color changing options, both fixtures are capable of dynamically lighting the space based on user preference, across a variety of applications.
Saturn's broad color palette is fit for use—ranging from wayfinding and branding, to mood creation and circadian support—all while complementing the design of the space. A unique feature of this new series is the motion sensor (MS) option. When selected with switchable perimeter and sensing occupancy, the center and perimeter are factory set to white mode. When sensing non-occupancy, the center turns off and the perimeter switches to the selected color (amber or red), based on its intended use: either as a nightlight or for wildlife protection.
According to Patricia Rizzo, product marketing manager for Kenall's healthcare vertical, "Through the use of color, Saturn enables design professionals to align the lighting more closely with the building's interior design. This exciting new luminaire provides an unlimited palette by which lighting specifiers can create a more visually interesting extension of the space. Use of the available synchronous or dual light engines provides ultimate control, allowing Saturn's colorful rings to add a subtle to dynamic, but always stylish, element to any lighting project."
About KenallKenall Manufacturing, a Legrand company, was founded in Chicago, Illinois in 1963 and has built a reputation for durable lighting solutions of superior quality and exceptional value. Today, the company creates specialized solutions for the healthcare, cleanroom/containment, food processing, transportation, high abuse, and correctional lighting markets. Kenall luminaires are designed and manufactured in Kenosha, Wisconsin, and comply with the Buy American Act.
About LegrandLegrand is the global specialist in electrical and digital building infrastructures. Its comprehensive offering of solutions for commercial, industrial, and residential markets makes it a benchmark for customers worldwide. The Group harnesses technological and societal trends with lasting impacts on buildings with the purpose of improving lives by transforming the spaces where people live, work and meet with electrical, digital infrastructures and connected solutions that are simple, innovative and sustainable. Drawing on an approach that involves all teams and stakeholders, Legrand is pursuing its strategy of profitable and sustainable growth driven by acquisitions and innovation, with a steady flow of new offerings—including Eliot connected products with enhanced value in use. The company is listed on Euronext Paris and is notably a component stock of the CAC 40 and CAC 40 ESG indexes (ISIN code FR0010307819). Legrand Group
View original content to download multimedia:https://www.prnewswire.com/news-releases/kenall-colors-healthcare-and-high-abuse-spaces-with-medmaster-saturn-302442006.html
SOURCE Kenall Manufacturing
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
PIF 與 FIFA 攜手，共同舉辦 FIFA Club World Cup 2025™
蘇黎世 & 沙特阿拉伯利雅得--(BUSINESS WIRE)--(美國商業資訊)-- PIF 與 FIFA 今日宣佈，PIF 成為 FIFA Club World Cup 2025™ 的官方合作夥伴，賽事將於 2025 年 6 月 14 日至 7 月 13 日在美國舉行。 此次合作展現了 PIF 與 FIFA 的共同願景，即透過創造新機遇、推動創新和吸引全球球迷，來實現更廣泛的體育參與。合作將重點關注青少年，為年輕群體創造機遇，助力 FIFA 深化基層足球推廣。 FIFA Club World Cup 2025™ 是球會足球全球舞台上的新篇章，將匯聚來自 FIFA 六大洲足協的冠軍球隊，共計 32 支頂級球會，在美國 11 個城市展開為期一個月的巔峰對決。 FIFA 首席商務官 Romy Gai 表示：「我們非常高興 PIF 成為 FIFA Club World Cup 2025™ 的合作夥伴。我們期待攜手打造這場歷史性的賽事，激勵並凝聚來自世界各地的球迷。」 「首屆 32 隊制 FIFA Club World Cup 的合作夥伴與我們一樣，致力於實現足球真正全球化的願景。他們的支援不僅是賽事成功的關鍵，也為全球球會足球的發展注入強勁動力。」 PIF 企業品牌主管 Mohammed AlSayyad 表示：「PIF 正在透過多項策略合作，在體育領域打造變革性影響，為球員、球迷和主辦城市社區帶來積極和持久的成果。 「繼去年宣佈與 Concacaf 合作以及我們對足球的持續投資後，PIF 始終站在推動全球足球發展的前沿。我們正不斷開拓機遇，加速這項運動在世界範圍內的發展。」 足球在沙特阿拉伯持續轉型中扮演著關鍵角色。作為 FIFA World Cup 2034™ 的主辦國，進一步彰顯了沙特推動全球足球發展、創造新機遇，並讓這項運動的積極影響惠及本國及全球，造福後人。 FIFA Club World Cup 2025™ 將在美國 11 個城市的 12 座球場舉行，賽事共 63 場。決賽將於 7 月 13 日（星期日）在新澤西州的 MetLife Stadium 上演，屆時將誕生新的 FIFA 球會世界冠軍。 所有賽事將在 免費直播，全球球迷可網上同步觀賽。門票及包含門票的觀賽套餐可透過 購買。 關於 PIF PIF 是推動沙特阿拉伯及全球經濟轉型的投資引擎。透過實施 Vision 2030 策略，PIF 在項目、企業和合作夥伴等層面持續投入，推動沙特經濟多元化，促進各領域增長，創造投資與就業新機遇。 作為全球投資者和變革催化劑，PIF 積極與世界各地最具開創性的組織合作，助力其增長，並引進技術與知識，推動構建未來產業生態系統。 自 2017 年以來，PIF 已設立 103 家公司，並透過在沙特公共及私營領域的策略投資與合作，引領經濟可持續發展轉型。PIF 正為本地和國際合作夥伴投資沙特的經濟和社會轉型奠定基礎。 免責聲明：本公告之原文版本乃官方授權版本。譯文僅供方便瞭解之用，煩請參照原文，原文版本乃唯一具法律效力之版本。
Yahoo
3 hours ago
- Yahoo
HOTELEX 2025 Successfully Concludes: International Attendance Surpasses 10,000, Hosted Buyer Program Sets a New Industry Benchmark!
SHANGHAI, June 6, 2025 /PRNewswire/ -- HOTELEX 2025 concluded on April 2 at the National Exhibition and Convention Center (Shanghai), covering 400,000 square meters and attracting 284,581 visitors. International attendance reached 12,447, a 34.2% increase from last year, marking HOTELEX's growing role as a key global hub for the hospitality and catering industry. A standout highlight this year was the success of the HOTELEX 2025 Hosted Buyer Program, which brought over 200 high-profile buyers from Malaysia, South Korea, Kazakhstan, Hong Kong (China), Brazil, and the United Kingdom to the show floor. Representing key sectors such as luxury hotel groups, branded F&B chains, import distributors, and regional procurement agencies, these buyers engaged in in-depth business discussions with top-tier exhibitors. With tailored matchmaking, curated meeting schedules, and dedicated services, the program enabled efficient, high-quality interactions and facilitated tangible international sourcing opportunities. Its success further strengthened HOTELEX's position as a premier global platform for hospitality and foodservice trade. Looking ahead to HOTELEX 2026 which will be held on 30th March - 2nd April at National Exhibition and Convention Center (Shanghai), the industry awaits new innovations, expanded collaborations, and broader global participation. Stay tuned for more—and we look forward to welcoming you next year. Booth Inquiry: Media Cooperation & Hosted Buyer Program: View original content to download multimedia: SOURCE HOTELEX Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Idorsia publishes invitations to bondholder meetings
Ad hoc announcement pursuant to Art. 53 LR Bondholder meetings will take place on Wednesday, June 25, 2025, to vote on proposals to amend the terms of the two outstanding convertible bonds CB 2025 and CB 2028 Allschwil, Switzerland – June 6, 2025Idorsia Ltd (SIX: IDIA) today announced that following the expiry of the appeal period for the amended terms approved at the CB 2025 bondholder meeting of February 25, 2025 – during which no appeal was filed – it has published invitations to the next bondholder meetings for holders of its outstanding CHF 200 million convertible bonds maturing in 2025 (CB 2025; ISIN CH0426820350), and CHF 600 million convertible bonds maturing in 2028 (CB 2028; ISIN CH1128004079). At the meetings, the company will propose changing the current terms of the CB 2025 and CB 2028 as part of the larger holistic restructuring, as announced in a press release on February 26, 2025, and an update published on May 21, 2025. To date, approximately 87% of the holders of the CB 2025 and 90% of holders of the CB 2028 have entered a legally binding lockup agreement in support of the holistic restructuring. Such bondholders have committed to vote in favour of the proposed amendments to the terms of the CB 2025 and CB 2028 at or before the meeting. The amendment of the terms of the CB 2025 and CB 2028 will be conditional on the consummation of the exchange offer, which is expected to be launched around or following the date of the bondholder meetings. Bondholders can access the invitations to the two bondholder meetings scheduled for Wednesday, June 25, 2025, including the terms of the resolution and additional information about the meeting, as well as a financial status report as of April 30, 2025, at the following links: and Notes to the editor About IdorsiaIdorsia Ltd is reaching out for more – we have more passion for science, we see more opportunities, and we want to help more patients. The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most. To achieve this, we will discover, develop, and commercialize transformative medicines – either with in-house capabilities or together with partners – and evolve Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ™ (daridorexant), a different kind of insomnia treatment with the potential to revolutionize this mounting public health concern; strong partners to maximize the value of our portfolio; a promising in-house development pipeline; and a specialized drug discovery engine focused on small-molecule drugs that can change the treatment paradigm for many patients. Idorsia is listed on the SIX Swiss Exchange (ticker symbol: IDIA). For further information, please contact:Investor & Media RelationsIdorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, CH-4123 Allschwil+41 58 844 10 – – The above information contains certain "forward-looking statements", relating to the company's business, which can be identified by the use of forward-looking terminology such as "estimates", "believes", "expects", "may", "are expected to", "will", "will continue", "should", "would be", "seeks", "pending" or "anticipates" or similar expressions, or by discussions of strategy, plans or intentions. Such statements include descriptions of the company's investment and research and development programs and anticipated expenditures in connection therewith, descriptions of new products expected to be introduced by the company and anticipated customer demand for such products and products in the company's existing portfolio. Such statements reflect the current views of the company with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements of the company to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated or expected. Attachment Press Release PDF
